Group of Clinical ResearchDivision of Experimental Therapeutics (Kashiwa)

The Division of Experimental Therapeutics supports efforts toward the creation of new drugs and other products from breakthroughs originating from academic institutions by achieving results at the level of basic research. We evaluate and discover excellent research and development proposals, and provide integrated management of the program so that basic research outcomes are linked through to clinical research and clinical trial for approval.

We have conducted several IITs as applications for approval and also have promoted research and development in the field of medicine. In clinical, the top priority is to conduct the FIH trials, and we also perform the phase I trials for solid tumors (i.e., all comers). Routine web-conference are also held between NCC-hospital (Tokyo) and NCC-East hospital (Kashiwa) every Friday morning, and we are sharing information about adverse events, patient enrollment and are referring the candidate each other to accelerate enrollment.